General Atlantic LLC Cin Cor Pharma, Inc. Transaction History

General Atlantic LLC

  • $3.5 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$19.9 - $38.94 $1.65 Million - $3.23 Million
83,000 Added 2.01%
4,209,470 $138 Million
Q1 2022

May 16, 2022
BUY
$14.13 - $28.49 $58.3 Million - $118 Million
4,126,470 New
4,126,470 $72.4 Million

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track General Atlantic LLC Portfolio

Follow General Atlantic LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Atlantic LLC, based on Form 13F filings with the SEC.

News

Stay updated on General Atlantic LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email